Multifunctional magnetic nanoparticles for targeted imaging and therapy.
暂无分享,去创建一个
[1] A. Bjørnerud,et al. NC100150 injection, a preparation of optimized iron oxide nanoparticles for positive‐contrast MR angiography , 2000, Journal of magnetic resonance imaging : JMRI.
[2] Thomas Wisniewski,et al. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging , 2003, Magnetic resonance in medicine.
[3] Ralph Weissleder,et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.
[4] J. Bacri,et al. Biomedical applications of maghemite ferrofluid. , 1998, Biochimie.
[5] S. H. Koenig,et al. ‘NC100150’, a preparation of iron oxide nanoparticles ideal for positive-contrast MR angiography , 1999, Magnetic Resonance Materials in Physics, Biology and Medicine.
[6] Ralph Weissleder,et al. Nanoparticle imaging of integrins on tumor cells. , 2006, Neoplasia.
[7] Peter van Gelderen,et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.
[8] R. Weissleder,et al. Magnetic resonance imaging of liver tumors. , 1989, Seminars in ultrasound, CT, and MR.
[9] C. Hoeller,et al. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. , 2004, Magnetic resonance imaging.
[10] R. Weissleder,et al. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.
[11] Ralph Weissleder,et al. “Clickable” Nanoparticles for Targeted Imaging , 2006, Molecular imaging.
[12] Peter Libby,et al. The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.
[13] Anna Moore,et al. In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.
[14] Ralph Weissleder,et al. In Vivo Phage Display Selection Yields Atherosclerotic Plaque Targeted Peptides for Imaging , 2006, Molecular Imaging and Biology.
[15] Ralph Weissleder,et al. A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI. , 2003, Molecular imaging.
[16] T J Brady,et al. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. , 1992, Radiology.
[17] C. Compton,et al. Ferrite-enhanced MR imaging of hepatic lymphoma: an experimental study in rats. , 1987, AJR. American journal of roentgenology.
[18] T. Nishimura,et al. Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma , 2005, British Journal of Cancer.
[19] Zhichuan J. Xu,et al. Controlled synthesis and chemical conversions of FeO nanoparticles. , 2007, Angewandte Chemie.
[20] R. Edelman,et al. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging. , 2000, Clinical radiology.
[21] B. Hamm,et al. Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging , 2004, Investigative radiology.
[22] Raoul Kopelman,et al. Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors , 2006, Clinical Cancer Research.
[23] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[24] Ralph Weissleder,et al. Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.
[25] Xiaoping P. Hu,et al. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent , 2004, JBIC Journal of Biological Inorganic Chemistry.
[26] J. Gillard,et al. Noninvasive imaging of carotid plaque inflammation , 2004, Neurology.
[27] Ralph Weissleder,et al. Annexin V–CLIO: A Nanoparticle for Detecting Apoptosis by MRI , 2002, Academic radiology.
[28] Akiyoshi Wada,et al. Dextran-magnetite: A new relaxation reagent and its application to T2 measurements in gel systems , 1978 .
[29] R. Weissleder,et al. Detection of macrophage activity in atherosclerosis in vivo using multichannel, high-resolution laser scanning fluorescence microscopy. , 2006, Journal of biomedical optics.
[30] M. Muhammed,et al. A High‐Performance Magnetic Resonance Imaging T2 Contrast Agent , 2007 .
[31] N. Devaraj,et al. Copper Catalyzed Azide‐Alkyne Cycloadditions on Solid Surfaces: Applications and Future Directions , 2007 .
[32] M. Joniau,et al. Mechanistic aspects of the adsorption of phospholipids onto lauric acid stabilized magnetite nanocolloids , 1991 .
[33] R. Weissleder,et al. The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide. , 1989, AJR. American journal of roentgenology.
[34] R. Weissleder,et al. Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. , 2006, Bioconjugate chemistry.
[35] Ralph Weissleder,et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.
[36] Ralph Weissleder,et al. In vivo assessment of RAS-dependent maintenance of tumor angiogenesis by real-time magnetic resonance imaging. , 2005, Cancer research.
[37] J A Frank,et al. Magnetoferritin: Characterization of a novel superparamagnetic MR contrast agent , 1994, Journal of magnetic resonance imaging : JMRI.
[38] Ralph Weissleder,et al. Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis , 2008, Circulation.
[39] R. Weissleder,et al. Human transferrin receptor gene as a marker gene for MR imaging. , 2001, Radiology.
[40] George M. Whitesides,et al. Magnetic separations in biotechnology , 1983 .
[41] Vasilis Ntziachristos,et al. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. , 2003, Neoplasia.
[42] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[43] R. Weissleder,et al. MR imaging of splenic metastases: ferrite-enhanced detection in rats. , 1987, AJR. American journal of roentgenology.
[44] J. Bacri,et al. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. , 2003, Biomaterials.
[45] R. Weissleder,et al. In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. , 2005, Bioconjugate chemistry.
[46] Jan Grimm,et al. Novel Nanosensors for Rapid Analysis of Telomerase Activity , 2004, Cancer Research.
[47] R Weissleder,et al. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.
[48] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[49] Mauro Ferrari,et al. The Molecular Analysis of Breast Cancer Utilizing Targeted Nanoparticle Based Ultrasound Contrast Agents , 2005, Technology in cancer research & treatment.
[50] R. Weissleder,et al. Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.
[51] S. Dhanasekaran,et al. Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.
[52] Anna Moore,et al. In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe , 2004, Cancer Research.
[53] R. Weissleder,et al. Nanoparticles for the optical imaging of tumor E-selectin. , 2005, Neoplasia.
[54] R Weissleder,et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. , 1988, Radiology.
[55] Jurgen E Schneider,et al. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide , 2007, Nature Medicine.
[56] R. Weissleder,et al. Splenic Imaging with Ultrasmall Superparamagnetic Iron Oxide Ferumoxtran-10 (AMI-7227): Preliminary Observations , 2001, Journal of computer assisted tomography.
[57] R. Weissleder,et al. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. , 1990, Radiology.
[58] R. Weissleder,et al. Development of nanoparticle libraries for biosensing. , 2006, Bioconjugate chemistry.
[59] R Weissleder,et al. Improvement of MRI probes to allow efficient detection of gene expression. , 2000, Bioconjugate chemistry.
[60] Ralph Weissleder,et al. In vivo imaging of molecularly targeted phage. , 2006, Neoplasia.
[61] D. Larkman,et al. Detection of vascular expression of E-selectin in vivo with MR imaging. , 2006, Radiology.
[62] R. Ivkov,et al. Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy , 2005, Clinical Cancer Research.
[63] Ralph Weissleder,et al. Sensitive, Noninvasive Detection of Lymph Node Metastases , 2004, PLoS medicine.
[64] L. Silengo,et al. Quantification of the expression level of integrin receptor αvβ3 in cell lines and MR imaging with antibody‐coated iron oxide particles , 2006 .
[65] R. Weissleder,et al. Cellular Imaging of Inflammation in Atherosclerosis Using Magnetofluorescent Nanomaterials , 2006, Molecular imaging.
[66] R Weissleder,et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.
[67] Ralph Weissleder,et al. Magnetic relaxation switches capable of sensing molecular interactions , 2002, Nature Biotechnology.
[68] R. Weissleder,et al. Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes. , 1994, Biochimica et biophysica acta.
[69] C. W. Jung. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.
[70] J. Bulte,et al. Magnetoliposomes as contrast agents. , 2003, Methods in enzymology.
[71] Michael J Sailor,et al. Biomimetic amplification of nanoparticle homing to tumors , 2007, Proceedings of the National Academy of Sciences.
[72] Ralph Weissleder,et al. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. , 2002, Bioconjugate chemistry.
[73] Robert Langer,et al. Magnetic relaxation switch detection of human chorionic gonadotrophin. , 2007, Bioconjugate chemistry.
[74] A. P. Alivisatos,et al. A new nonhydrolytic single-precursor approach to surfactant-capped nanocrystals of transition metal oxides , 1999 .
[75] C. Bárcena,et al. APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE , 2003 .
[76] Martin J Graves,et al. In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI , 2004, Stroke.
[77] R. Weissleder,et al. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.
[78] Alexander Petrovsky,et al. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. , 2002, Bioconjugate chemistry.
[79] Ralph Weissleder,et al. Detection of early prostate cancer using a hepsin-targeted imaging agent. , 2008, Cancer research.
[80] Ralph Weissleder,et al. Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.
[81] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[82] R Weissleder,et al. Improved delineation of human brain tumors on MR images using a long‐circulating, superparamagnetic iron oxide agent , 1999, Journal of magnetic resonance imaging : JMRI.
[83] M. D. Butterworth,et al. Development of Systems for Targeting the Regional Lymph Nodes for Diagnostic Imaging: In Vivo Behaviour of Colloidal PEG-Coated Magnetite Nanospheres in the Rat Following Interstitial Administration , 2001, Pharmaceutical Research.
[84] J. Le Bas,et al. Ultrasmall particulate iron oxides as contrast agents for magnetic resonance spectroscopy: A dose‐effect study , 2001, Journal of magnetic resonance imaging : JMRI.
[85] Ralph Weissleder,et al. A macrophage-targeted theranostic nanoparticle for biomedical applications. , 2006, Small.
[86] P. Jallet,et al. Nonpolymeric Coatings of Iron Oxide Colloids for Biological Use as Magnetic Resonance Imaging Contrast Agents. , 2001, Journal of colloid and interface science.